NEW YORK, NY, UNITED STATES - Feb 23, 2015 - Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has been selected to support theChildhood Arthritis and Rheumatology Research Alliance (CARRA) Registry, a 10-year project to collect comprehensive data on pediatric rheumatic diseases and their treatments
National Network of Pediatric
Rheumatologists Leverages Medidata Clinical Cloud® to Align
Scientific Agenda and Expand Research in Area of Significant Unmet
Need
NEW YORK, NY, UNITED STATES - Feb 23, 2015 -
Medidata (NASDAQ:MDSO), the leading global provider of
cloud-based solutions for clinical research in life sciences, today
announced that it has been selected to support theChildhood
Arthritis and Rheumatology Research Alliance (
CARRA) Registry, a 10-year project to collect comprehensive
data on pediatric rheumatic diseases and their treatments.
"While we've made huge progress in the last decade, 300,000
children and families in the US alone are affected by rheumatic
diseases," said Laura Schanberg, MD, professor of pediatrics
at Duke University and CARRA president and the principal
investigator for the CARRA Registry, an observational study of
children and adolescents with major rheumatic diseases. By powering
data capture for the scalable informatics infrastructure of the
CARRA Registry, the
Medidata Clinical Cloud® will help CARRA develop a
resource for patients, physicians and researchers seeking to learn
more about pediatric rheumatic diseases, and, ultimately, drive
better diagnostic and treatment approaches.
In support of its long-term research efforts, the registry is
leveraging Medidata's cloud-based technology for electronic data
capture and management (
Medidata Rave®) and mobile solution for patient-direct data
capture (
Medidata Patient Cloud®). A mobile app unified with
Medidata's platform, Patient Cloud brings new
efficiencies to the administration of electronic patient-reported
outcomes (ePROs) in clinical trials and registries. The mobile app
provides electronic patient questionnaires and diaries in a model
that simplifies the process for both patients and researchers.
"Using Medidata's platform in combination with the open-source,
i2b2 federated clinical research data warehouse platform already in
use for the CARRA Registry, this post-marketing surveillance
network will collect at least 10 years of comprehensive
information, including detailed safety and treatment data, on
pediatric rheumatic disorders in the US and Canada,"
said Marc Natter, MD, the CARRA Registry's director of
informatics development and instructor in the Boston Children's
Hospital Informatics Program. "This is a critical next step in
understanding how to best apply available therapies and improve the
systems for studying the safety and efficacy of treatment options
for childhood-onset arthritis."
Dedicated to advancing the health and quality of life of
children living with rheumatic disease and arthritis, CARRA was
formed by pediatric rheumatologists seeking to answer critical
clinical research questions. "Juvenile idiopathic arthritis and
other pediatric inflammatory disorders result in persistent joint
pain, swelling and stiffness of joints, decreased activity, and
potentially growth and eye problems," Schanberg added. "Children
lose days from school, parents lose days from work and quality of
life suffers greatly. We believe that simplifying data capture and
patient participation processes will catapult the field of
pediatric rheumatology research to the level of performance
necessary to realize dramatic improvements in outcomes and quality
of life for all children with rheumatic disease."
Glen de Vries, Medidata's president, said: "We're excited to be
partnering with CARRA on this observational study and proud that
our technology platform is helping to further the alliance's
important mission to prevent, treat and cure arthritis and other
rheumatic diseases in children and adolescents. All of us at
Medidata share CARRA's commitment to fostering, facilitating and
conducting high-quality research that advances the development of
new, enhanced diagnostic and treatment approaches."
Connect with Medidata:
About CARRA
CARRA is a North American non-profit research organization of
more than 400 pediatric rheumatologists, researchers and research
coordinators at more than 100 sites (95% of all pediatric
rheumatologists/sites in North America) who are working
together to find treatments for juvenile idiopathic arthritis and
other pediatric rheumatic diseases in children.
The CARRA Registry is a cornerstone of CARRA and provides
disease and treatment data on children with a variety of rheumatic
diseases. CARRA aims to make it possible for all affected children
in North Americato have the opportunity to participate in
meaningful and high quality clinical and translational research.
CARRA researchers have been awarded over $40 million in
research funding over the last 10 years. In addition to Dr.
Schanberg, the CARRA Executive team includes Yukiko Kimura,
MD, Hackensack University Medical Center, Norman Ilowite,
MD, Montefiore Medical Center, and Robert Fuhlbrigge, MD,
PhD, Boston Children's Hospital.
For questions about CARRA, contact executive director
Kelly Mieszkalski at kelly.m@carragroup.org.
About Medidata Solutions
Medidata is the leading global provider of cloud-based
solutions for clinical research in life sciences, transforming
clinical development through its advanced applications and
intelligent data analytics. The Medidata Clinical
Cloud® brings new levels of productivity and quality to the
clinical testing of promising medical treatments, from study design
and planning through execution, management and reporting. We are
committed to advancing the competitive and scientific goals of
global customers, which include over 90% of the top 25 global
pharmaceutical companies; innovative biotech, diagnostic and device
firms; leading academic medical centers; and contract research
organizations.
Investor:
Medidata Solutions
Hulus Alpay, 212-419-1025
halpay@mdsol.com
or
Media:
Medidata Solutions
Nicole Pariser, 212-659-1069
npariser@mdsol.com